Prostate Cancer Clinical Trials in Miami

Showing 101-115 of 115 trials

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

NCT02080689

The influence of Decipher test on urologist and patient treatment plan choices immediately post RP and at the time of PSA rise or BCR

Prostate Cancer

GenomeDx Biosciences Corp286 participantsStarted May 2014

Anchorage, Alaska, United States • Los Angeles, California, United States • Aurora, Colorado, United States +16 more locations

TERMINATEDPhase 1/2< 1 mile

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

NCT00503984

Azacitidine can reverse clinical resistance to docetaxel through upregulation of Growth Arrest and DNA Damage inducible alpha (GADD45α) and other epigenetically regulated genes.

Prostate CancerPain

University of Miami22 participantsStarted May 2007

Miami, Florida, United States

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

Prostate Cancer Trials in Other Cities

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management

Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer

DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Other Conditions in Miami